Garware Fulflex has completed the acquisition of a 300,000-square-foot manufacturing facility in the United States focused on medical products, according to both sources. The facility is described as fully automated and dedicated to producing medical-related products. The announcements emphasize the size of the plant and its automation capabilities, positioning the acquisition as an expansion of Garware Fulflex’s U.S. manufacturing footprint for medical production.
Both outlets report the completion of the deal and use the same core details: the buyer is Garware Fulflex, the purchased site is 300,000 square feet, and it operates as a fully automated manufacturing facility for medical products in the United States. Neither source provides additional context such as the seller’s identity, the deal value, the acquisition timeline beyond completion, or the planned product lines. The reporting is therefore limited to the completion status and facility characteristics.
